TNF and Crohn disease: The 2020 ECCO-ESPGHAN guidelines on the medical management of pediatric Crohn’s disease [11] use POPO to select patients who are at low-, moderate- and high-risk of poor outcome and to recommend the respective first-line therapies for these groups, including exclusive enteral nutrition, steroids, anti-TNF, or surgery.